VASCULAR BIOGENICS LTD shareholders Q1 2023

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 18 filers reported holding VASCULAR BIOGENICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

VASCULAR BIOGENICS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Spectrum Planning & Advisory Services Inc. 16,000$2,6810.00%
Virtu Financial LLC 37,424$60.00%
Affinity Capital Advisors, LLC 22,265$3,7290.00%
MORGAN STANLEY 409,011$68,5090.00%
HBK Sorce Advisory LLC 20,575$3,4470.00%
Bank of New York Mellon Corp 39,000$6,5330.00%
Harel Insurance Investments & Financial Services Ltd. 11,000$20.00%
SIMPLEX TRADING, LLC 100$00.00%
Tower Research Capital LLC (TRC) 937$00.00%
ROYAL BANK OF CANADA 798$00.00%
NewEdge Advisors, LLC 1,700$2850.00%
BNP PARIBAS FINANCIAL MARKETS 100$170.00%
TWO SIGMA INVESTMENTS, LP 17,800$2,9820.00%
OSAIC HOLDINGS, INC. 22,491$3,7640.00%
BANK OF AMERICA CORP /DE/ 8,192$1,3690.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 170,493$28,5920.00%
GEODE CAPITAL MANAGEMENT, LLC 40,323$6,7620.00%
External links

This page lists VASCULAR BIOGENICS LTD's shareholders in Q1 2023. To view VASCULAR BIOGENICS LTD's shareholder history, click here.